|
The Neuroendocrine Center is an internationally recognized
research center in neuroendocrinology and pituitary disease.
Investigators in the Center have been awarded 14 NIH and
federal research grants. In addition, funding from industry
and private foundations includes the awarding of one of
six Global Endocrinology and Metabolism (GEM Centers) for
investigator initiated research by Pharmacia; investigator
initiated grants from Novartis to study somatostatin receptor
subtypes and pituitary tumors; and participation in international
clinical research studies.
Research Protocols
- A study to compare the efficacy and safety of pegvisomant
to that of sandostatin LAR depot in
patients with acromegaly
- Does surgical debulking of pituitary adenomas improve
responsiveness to octreotide lar in the treatment of
acromegaly: An investigator-initiated study
- A multi-center, open-label compassionate use program
to provide pegvisomant to acromegaly patients refractory
to conventional therapy
Read
more on clinical research in endocrine cancers.
|
